drugset / Trial / NCT00901719

Investigating Systemic and Local Vascular Responses to Apelin in the Context of Renin-angiotensin Upregulation

NCT00901719

RandomizedCrossoverSingle-blindBasic science

Summary

The apelin-APJ system is a relatively new discovery. It has generated interest in part due to it's apparent ability to counteract the renin-angiotensin system, which is frequently overactive in many cardiovascular disease. Two of the main actions of apelin are to increase the pumping ability of the heart and cause blood vessels to relax. The investigators wish to assess if these actions are altered in the setting of normal renin-angiotensin activation and increased renin-angiotensin activity.

Timeline

Start
2010-04
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylcholine Small molecule 5 ug Other
Subject Acetylcholine Small molecule 10 ug Other
Subject Acetylcholine Small molecule 20 ug Other
Subject Apelin Peptide 0.3 unknown Other
Subject Apelin Peptide 1 unknown Other
Subject Apelin Peptide 3 unknown Other
Subject Apelin Peptide 30 unknown Other
Subject Apelin Peptide 100 unknown Other
Subject Apelin Peptide 300 unknown Other
Subject Sodium Nitroprusside Unknown 1 ug Other
Subject Sodium Nitroprusside Unknown 2 ug Other
Subject Sodium Nitroprusside Unknown 4 ug Other

Indications